VANCOUVER, May 1, 2018 /CNW/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQB:IMLFF), a fully integrated, cannabinoid -based biopharmaceutical company that leverages its proprietary bioinformatics and biosynthesis platform technologies to develop novel therapeutics for … Read More
The post InMed Appoints Dr. Vikramaditya G. Yadav to Scientific Advisory Board appeared first on Dagga Magazine.